Marella Thorell - 13 Jul 2022 Form 3 Insider Report for Evelo Biosciences, Inc.

Role: Chief Financial Officer
Signature: /s/ Daniel S. Char, Attorney-in-Fact for Marella Thorell
Issuer symbol: EVLO on OTC
Transactions as of: 13 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 18 Jul 2022, 16:22:13 UTC
Previous filing: 06 Jul 2022
Next filing: 01 Sep 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney